UPDATE : Wednesday, December 12, 2018
상단여백
‘Bispecific antibody market offers promising outlook’ by Nam Doo-hyun 2018-12-12 16:27
‘Korea should protect pathogen resources under Nagoya Protocol’ by Nam Doo-hyun 2018-12-10 15:15
Trade ministry to support research of new biopharmaceutical drugs by Nam Doo-hyun 2018-12-07 14:54
Local drugmakers rank high in clinical trial approval by Nam Doo-hyun 2018-12-06 11:15
‘New combo drug could lower blood pressure early’ by Nam Doo-hyun 2018-12-05 14:01
라인
Doctors have fun on concert stage offered by drugmaker by Nam Doo-hyun 2018-12-04 14:31
Prescriptions of anticancer drugs spiked this year by Nam Doo-hyun 2018-11-30 13:01
‘Rules to be tougher on patent transfer due to ToolGen case’ by Nam Doo-hyun 2018-11-29 11:48
Samsung BioLogics files administrative suit to refute accounting fraud ruling by Nam Doo-hyun 2018-11-28 15:30
Bayer’s liver cancer drug proves efficacy with real-world data by Nam Doo-hyun 2018-11-27 14:27
라인
Pharmaceuticals, biotechs rise with KOSPI rebound by Nam Doo-hyun 2018-11-27 11:53
Pharmaceuticals still use credit card kiting for illegal cash rebates by Nam Doo-hyun 2018-11-26 15:01
Operating income declines at top 10 biotechs on KOSDAQ by Nam Doo-hyun 2018-11-22 11:15
US data crucial for Korean biosimilars after success in Europe by Nam Doo-hyun 2018-11-21 15:29
MSD Korea improves employee welfare upon birth of union by Nam Doo-hyun 2018-11-21 12:56
라인
‘Pay attention to expansion of US online pharmacy market’ by Nam Doo-hyun 2018-11-20 16:05
Samsung BioLogics fiasco hardly affects biotech stocks by Nam Doo-hyun 2018-11-16 11:30
‘Team up with multinationals to become multinational’ by Nam Doo-hyun 2018-11-15 11:20
Seoul mayor vows to support biomedical industry by Nam Doo-hyun 2018-11-14 15:34
Orders for ingredients of antitussives, expectorants surge amid fine dust by Nam Doo-hyun 2018-11-14 11:48
여백
여백
여백
Back to Top